Stock Track | AxoGen Plunges 10.97% in Pre-Market After Q4 Earnings Miss Estimates

Stock Track02-24

AxoGen Inc. shares plummeted 10.97% in pre-market trading on Tuesday following the release of its fourth-quarter financial results.

The medical technology company reported quarterly earnings of $0.07 per share, which fell short of the analyst consensus estimate of $0.08 per share, representing a miss of 12.5%. While quarterly sales of $59.904 million exceeded the $58.870 million estimate, the earnings disappointment appears to have driven investor sentiment. The company also reported a Q4 net loss of $13.2 million alongside an adjusted EBITDA of $6.5 million.

Concurrently, management provided forward-looking guidance, expecting 2026 revenue growth of at least 18% and anticipating the company will be free cash flow positive for the full year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174372468?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174372468","market":"us","top_or_hot":-1,"title":"Stock Track | AxoGen Plunges 10.97% in Pre-Market After Q4 Earnings Miss Estimates","media":"Stock Track","content":"<p>AxoGen Inc. shares plummeted 10.97% in pre-market trading on Tuesday following the release of its fourth-quarter financial results.</p><p>The medical technology company reported quarterly earnings of $0.07 per share, which fell short of the analyst consensus estimate of $0.08 per share, representing a miss of 12.5%. While quarterly sales of $59.904 million exceeded the $58.870 million estimate, the earnings disappointment appears to have driven investor sentiment. The company also reported a Q4 net loss of $13.2 million alongside an adjusted EBITDA of $6.5 million.</p><p>Concurrently, management provided forward-looking guidance, expecting 2026 revenue growth of at least 18% and anticipating the company will be free cash flow positive for the full year.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | AxoGen Plunges 10.97% in Pre-Market After Q4 Earnings Miss Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | AxoGen Plunges 10.97% in Pre-Market After Q4 Earnings Miss Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-24 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>AxoGen Inc. shares plummeted 10.97% in pre-market trading on Tuesday following the release of its fourth-quarter financial results.</p><p>The medical technology company reported quarterly earnings of $0.07 per share, which fell short of the analyst consensus estimate of $0.08 per share, representing a miss of 12.5%. While quarterly sales of $59.904 million exceeded the $58.870 million estimate, the earnings disappointment appears to have driven investor sentiment. The company also reported a Q4 net loss of $13.2 million alongside an adjusted EBITDA of $6.5 million.</p><p>Concurrently, management provided forward-looking guidance, expecting 2026 revenue growth of at least 18% and anticipating the company will be free cash flow positive for the full year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AXGN","symbol_name":"AxoGen Inc.","start_time":0,"source_url":"","article_id":"1174372468","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174372468","pubTimestamp":1771935052,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"AxoGen Inc. shares plummeted 10.97% in pre-market trading on Tuesday following the release of its fourth-quarter financial results.The medical technology company reported quarterly earnings of $0.07...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AXGN":"AxoGen Inc."},"translate_title":"个股追踪|Q4财报不及预期AxoGen盘前暴跌10.97%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AXGN":1},"content_text":"AxoGen Inc. shares plummeted 10.97% in pre-market trading on Tuesday following the release of its fourth-quarter financial results.The medical technology company reported quarterly earnings of $0.07 per share, which fell short of the analyst consensus estimate of $0.08 per share, representing a miss of 12.5%. While quarterly sales of $59.904 million exceeded the $58.870 million estimate, the earnings disappointment appears to have driven investor sentiment. The company also reported a Q4 net loss of $13.2 million alongside an adjusted EBITDA of $6.5 million.Concurrently, management provided forward-looking guidance, expecting 2026 revenue growth of at least 18% and anticipating the company will be free cash flow positive for the full year.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174372468","isCrawlerRequest":true}